Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma
PDF | Full Text | How to cite
Metrics: PDF 1186 views | Full Text 1365 views | ?
Yuzan Kudo1, Shiro Kohi1,2, Keiji Hirata1, Michael Goggins2 and Norihiro Sato1
1 Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
2 Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
|Norihiro Sato,||email:||[email protected]|
Keywords: hyaluronan; synthesis; degradation; pancreatic cancer; prognosis
Abbreviations: PDAC: pancreatic ductal adenocarcinoma; HA: hyaluronan; HAMP: hyaluronan activated-metabolism phenotype
Received: July 04, 2019 Accepted: August 12, 2019 Published: September 24, 2019
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.